STUDY OF THE PHARMACOKINETICS OF DOMESTIC ARIPIPRAZOLE IN HEALTHY VOLUNTEERS.
Qi Yu, Liang Mao-zhi
Abstract
Qi Yu, Liang Mao-zhi
Abstract
Objective:To determine aripiprazole in human plasma by developing a HPLC-UV method,and study the pharmacokinetics profiles of domestic aripiprazole tablets in healthy volunteers.Methods:The multiple oral doses of domestic aripiprazole were given to 14 healthy volunteers.Aripiprazole concentration in human plasma was determined by HPLC method.The pharmacokinetic parameters of aripiprazole were obtained with statistical analysis by DAS1.0.Result:In this study,the healthy volunteers took aripiprazole for 14 d to achieve steady state,and reached the peak concentration(480.3±126.2)μg·L~(-1) at(4.0±0.9)h after the last administration in steady state.AUC_(0-360h) was(38166.6±13241.2)μg·h·L~(-1),t_(1/2β) was(91.0±21.1h),CL/F was (0.62±0.36)L·h~(-1) and V/F was(60.9±43.7)L.Conclusion:The concentration-time curve of aripiprazole was conformed to a two-compartment open model.And it offered necessary information for clinical use of aripiprazole in Chinese.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To determine aripiprazole in human plasma by developing a HPLC-UV method,and study the pharmacokinetics profiles of domestic aripiprazole tablets in healthy volunteers.Methods:The multiple oral doses of domestic aripiprazole were given to 14 healthy volunteers.Aripiprazole concentration in human plasma was determined by HPLC method.The pharmacokinetic parameters of aripiprazole were obtained with statistical analysis by DAS1.0.Result:In this study,the healthy volunteers took aripiprazole for 14 d to achieve steady state,and reached the peak concentration(480.3±126.2)μg·L~(-1) at(4.0±0.9)h after the last administration in steady state.AUC_(0-360h) was(38166.6±13241.2)μg·h·L~(-1),t_(1/2β) was(91.0±21.1h),CL/F was (0.62±0.36)L·h~(-1) and V/F was(60.9±43.7)L.Conclusion:The concentration-time curve of aripiprazole was conformed to a two-compartment open model.And it offered necessary information for clinical use of aripiprazole in Chinese.
Key concepts: Aripiprazole, Pharmacokinetics, Pharmacology, Plasma concentration, Medicine, Schizophrenia (object-oriented programming), Psychiatry